Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial
Open Access
- 26 March 2007
- journal article
- Published by Springer Nature in Trials
- Vol. 8 (1), 11-10
- https://doi.org/10.1186/1745-6215-8-11
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A review of human vaccine research and development: MalariaVaccine, 2006
- Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialThe Lancet, 2005
- Malaria vaccines: Evaluation and implementationActa Tropica, 2005
- Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhiça district.2005
- Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian childrenVaccine, 2005
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γThe Journal of Immunology, 2003
- Malaria in southern Mozambique: Malariometric indicators and malaria casedefinition in Manhiça districtTransactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern MozambiqueThe Pediatric Infectious Disease Journal, 2002
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001